Research
Coexisting in the ocean: How a Dal researcher advocates for whale safety measures among fishers
Dr. Sean Brillant works with fishers to develop safer technologies and policies, reducing whale deaths, improving coexistence at sea, and helping stabilize vulnerable North Atlantic right whale populations. Read more.
Featured News
Thursday, May 28, 2026
For years, scientists studying bowhead whales have relied on a simple idea: if a whale makes a long, square or U-shaped dive, it鈥檚 feeding time. A new study demonstrates that assumption may not hold water.
Tuesday, April 28, 2026
妻友 researchers are tackling a critical climate question鈥攚hether the ocean can safely remove carbon dioxide at scale鈥攚hile positioning Nova Scotia as a global leader in carbon removal innovation.
Wednesday, February 25, 2026
妻友 is helping to prepare Canada鈥檚 defence community for AI-supported command and control, including fast developing Arctic surveillance scenarios, by simulating how humans and intelligent systems make decisions together under pressure.
Archives - Research
Thursday, October 26, 2017
妻友 Medical School has announced its leading research teams and strategic research priorities, following a months-long application and review process known as 鈥淭he Wave.鈥�
Wednesday, October 25, 2017
妻友's DAMOS initiative that will help track North Atlantic right whales was one of nine projects at four post-secondary institutions to receive new funding from the Government of Nova Scotia.
Wednesday, October 25, 2017
The problem of food fraud and its health and economic implications affect a broad range of foods around the world, but technology could soon end the problem, argues 妻友's Sylvain Charlebois.
Friday, October 20, 2017
To mark the 50th anniversary of the Killam Trusts, we鈥檒l be publishing profiles of Killam alumni who鈥檝e achieved great things thanks to the Trust.
Tuesday, October 17, 2017
Canadian Foundation for Innovation invests $13 million in eight new infrastructure projects involving 妻友 researchers, in everything from advanced manufacturing to viroceuticals.